Citadel Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-200,096
Closed -$177K 16222
2022
Q4
$177K Sell
200,096
-1,348,958
-87% -$1.79M ﹤0.01% 10353
2022
Q3
$2.43M Buy
1,549,054
+884,632
+133% +$2.01M ﹤0.01% 5215
2022
Q2
$1.33M Sell
664,422
-1,029,400
-61% -$1.78M ﹤0.01% 6381
2022
Q1
$3.95M Buy
1,693,822
+691,099
+69% +$2.16M ﹤0.01% 4640
2021
Q4
$4.66M Buy
1,002,723
+774,668
+340% +$4.81M 0.01% 4431
2021
Q3
$1.74M Buy
228,055
+154,832
+211% +$1.31M ﹤0.01% 6723
2021
Q2
$710K Sell
73,223
-503,355
-87% -$4.01M ﹤0.01% 9220
2021
Q1
$4.77M Buy
576,578
+521,598
+949% +$5.51M 0.01% 4361
2020
Q4
$375K Sell
54,980
-298
-0.5% -$2.39K ﹤0.01% 8680
2020
Q3
$616K Sell
55,278
-364,991
-87% -$3.34M ﹤0.01% 6917
2020
Q2
$2.64M Buy
+420,269
New +$1.61M ﹤0.01% 4085
2020
Q1
Hold
0
10478
2019
Q4
Sell
-298,565
Closed -$712K 10081
2019
Q3
$639K Sell
298,565
-62,748
-17% -$146K ﹤0.01% 6330
2019
Q2
$965K Buy
361,313
+318,848
+751% +$1.15M ﹤0.01% 5757
2019
Q1
$202K Sell
42,465
-218,610
-84% -$574K ﹤0.01% 8199
2018
Q4
$627K Buy
261,075
+247,468
+1,819% +$808K ﹤0.01% 6055
2018
Q3
$60K Sell
13,607
-64,075
-82% -$355K ﹤0.01% 8767
2018
Q2
$559K Buy
77,682
+53,703
+224% +$365K ﹤0.01% 6187
2018
Q1
$123K Buy
23,979
+11,393
+91% +$81.1K ﹤0.01% 7639
2017
Q4
$48K Sell
12,586
-20,137
-62% -$52.4K ﹤0.01% 7645
2017
Q3
$56K Buy
+32,723
New +$60K ﹤0.01% 7161
2017
Q2
Sell
-19,476
Closed -$77K 8389
2017
Q1
$77K Buy
+19,476
New +$97.7K ﹤0.01% 6941
2016
Q4
Sell
-14,100
Closed -$109K 8199
2016
Q3
$109K Buy
+14,100
New +$94.9K ﹤0.01% 6621
2016
Q1
Sell
-28,792
Closed -$251K 8382
2015
Q4
$251K Buy
28,792
+27,431
+2,016% +$231K ﹤0.01% 5488
2015
Q3
$11K Sell
1,361
-66,830
-98% -$1.06M ﹤0.01% 8439
2015
Q2
$1.2M Sell
68,191
-7,946
-10% -$102K ﹤0.01% 3729
2015
Q1
$880K Buy
+76,137
New +$881K ﹤0.01% 4097

Other funds holding SRNE